Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2224941 Title: Verwendung zelldurchlässiger peptidhemmer des JNK-signaltransduktionsweges zur behandlung chronischer oder nicht chronischer entzündungserkrankungen des verdauungstrakts

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
097536932
WO application number:
EP2009003936
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2224941
WO publication number:
WO 2009/144038
1rst applicant's nationality:
Translation language:
German
EPO publication language:
English
SPC number:

Dates

Filing date:
02/06/2009
Grant date:
29/02/2012
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
23/05/2012
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
29/02/2012
EP B1 publication date:
29/02/2012
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/06/2024
Expiration date (if granted and all annual fees paid):
02/06/2029

Applicant

1

Name:
Xigen Inflammation Ltd.
Legal Form:
From:
09/01/2014
Address:
Arch. Makariou III,195 Neocleous House,CH-3030 Limassol, -, Cyprus (CY)
To:

2

Name:
XIGEN S.A.
Legal Form:
From:
29/02/2012
Address:
-, -, Unknown (UNKNOWN)
To:
09/01/2014

Agent

Name:
LAMBERT Romain
Legal Form:
From:
23/05/2012
Address:
Route d'Arlon 234 P.O. Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
BONNY, Christophe
Legal Form:
Address:

Priority

Priority patent number:
PCT/EP2008/0
Priority date:
30/05/2008
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

Main IPC class:
A61K 38/01;
IPC or IDT classification:
A61K 38/03; A61K 38/04; A61P 1/04; A61P 29/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2012/02
Publication date:
29/02/2012
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
20/06/2023
Last annual fee paid number:
15
Last annual fee paid amount:
360 Euro
Payer:
DENNEMEYER & Co S.A.R.L.
Filing date Document type Publication Type Document Description Number of pages File Type
23/05/2012 General Document (F - F:Traduction déposée par fax) 127 PDF /1/4/9/4/2/0612224941/migrated-docs/097536932_1_292729.pdf
25/05/2012 General Document (OF - T:Traduction Originale de la traduction déposée par fax) 127 PDF /1/4/9/4/2/0612224941/migrated-docs/097536932_2_292729.pdf
20/12/2013 General Document (CS - S:Cession) 20 PDF /1/4/9/4/2/0612224941/migrated-docs/097536932_3_292729.pdf